Radiology – Thoracic Imaging

Medicine & Life Sciences

1. Thorax 100%
2. Lung 99%
3. Tomography 86%
4. Lung Neoplasms 56%
5. Glass 54%
6. Radiologists 50%
7. Adenocarcinoma of Lung 48%
8. Deep Learning 41%
9. Neoplasms 35%
10. Needle Biopsy 31%
11. Contrast Media 22%
12. Pulmonary Tuberculosis 22%
13. Cone-Beam Computed Tomography 21%
14. Adenocarcinoma 20%
15. Neoplasm Metastasis 19%
16. Pneumothorax 19%
17. Biopsy 19%
18. Emphysema 17%
19. Tuberculosis 16%
20. Radiography 16%
21. Confidence Intervals 16%
22. Computed Tomography Angiography 16%
23. Non-Small Cell Lung Carcinoma 15%
24. Perfusion 15%
25. Hemoptysis 15%
26. Xenon 14%
27. Early Detection of Cancer 14%
28. Coronavirus 14%
29. Pneumonia 14%
30. Radiology 13%
31. Bronchiectasis 13%
32. Lung Diseases 13%
33. ROC Curve 13%
34. Odds Ratio 12%
35. Rabbits 12%
36. Artificial Intelligence 12%
37. Area Under Curve 12%
38. Positron Emission Tomography Computed Tomography 11%
39. Fluorodeoxyglucose F18 11%
40. Ventilation 11%
41. Reading 11%
42. Liver 10%
43. Lymph Nodes 10%
44. Idiopathic Pulmonary Fibrosis 10%
45. Multidetector Computed Tomography 10%
46. Software 10%
47. Magnetic Resonance Imaging 10%
48. Fats 10%
49. Meta-Analysis 10%
50. Positron-Emission Tomography 10%
51. Recurrence 9%
52. Carcinoma 9%
53. Portion Size 9%
54. Data Systems 9%
55. Bronchi 9%
56. Retrospective Studies 9%
57. Survival 9%
58. Video-Assisted Thoracic Surgery 9%
59. Interstitial Lung Diseases 8%
60. Air 8%
61. Sensitivity and Specificity 8%
62. Datasets 8%
63. Radiation 8%
64. Chronic Obstructive Pulmonary Disease 8%
65. Mediastinum 8%
66. Logistic Models 8%
67. Regression Analysis 8%
68. Research Ethics Committees 8%
69. Cohort Studies 8%
70. Pulmonary Artery 7%
71. Multivariate Analysis 7%
72. Iodine 7%
73. ErbB Receptors 7%
74. Fibrosis 7%
75. Incidence 7%
76. Cysts 6%
77. Guidelines 6%
78. Coronary Artery Disease 6%
79. Neoplasm Staging 6%
80. Seoul 6%
81. X-Rays 6%
82. Gadolinium 6%
83. Informed Consent 6%
84. Renal Cell Carcinoma 6%
85. Growth 6%
86. Asthma 6%
87. Needles 6%
88. Hypersensitivity 6%
89. Bronchiolo-Alveolar Adenocarcinoma 6%
90. Pulmonary Emphysema 6%
91. Pulse Wave Analysis 5%
92. Adenocarcinoma in Situ 5%
93. Systematic Reviews 5%
94. Coronary Vessels 5%
95. Premedication 5%
96. Disease-Free Survival 5%
97. Artifacts 5%
98. Respiratory Function Tests 5%
99. Spiral Computed Tomography 5%
100. Therapeutics 5%